Rabemax 20 mg tablets

Rabeprazole sodium blocks the final stage of hydrochloric acid production by specifically inhibiting H+/K+ ATPase on the secretory surface of gastric parietal cells.

One enteric coated tablet contains :

• rabeprazole sodium – 20 mg.

• Peptic ulcer of the stomach and duodenum in the acute stage;
• Erosive or ulcerative gastroesophageal reflux disease or reflux esophagitis;
• Maintenance therapy for gastroesophageal reflux disease;
• Non-erosive gastroesophageal reflux disease;
• Zollinger-Ellison syndrome and other conditions characterized by pathological hypersecretion;
• In combination with appropriate antibacterial therapy for eradication Helicobacter pylori in patients with gastric and duodenal ulcers.

Directions for use and dosage: Rabemax tablets should not be chewed or crushed. The tablets should be swallowed whole 30 minutes before meals. For gastric ulcers in the acute stage and anastomotic ulcers, it is recommended to take 20 mg orally once a day. Usually cure occurs after 6 weeks of therapy, but in some cases the duration of treatment can be increased by another 6 weeks. For duodenal ulcers in the acute stage, it is recommended to take 20 mg orally once a day. The duration of treatment is from 2 to 4 weeks. If necessary, the duration of treatment can be increased by another 4 weeks.

When treating erosive gastroesophageal reflux disease or reflux esophagitis, it is recommended to take 20 mg orally once a day. The duration of treatment is from 4 to 8 weeks. If necessary, the duration of treatment can be increased by another 8 weeks. For maintenance therapy of gastroesophageal reflux disease, it is recommended to take 20 mg orally once a day. The duration of treatment depends on the patient's condition.

For non-erosive gastroesophageal reflux disease without esophagitis, it is recommended to take 20 mg orally once a day. If symptoms do not disappear after four weeks of treatment, the patient should be further examined. After relief of symptoms, to prevent their subsequent occurrence, the drug should be taken orally once a day as required.

For the treatment of Zollinger-Ellison syndrome and other conditions characterized by pathological hypersecretion, the dose is selected individually. The initial dose is 60 mg per day, then the dose is increased and the drug is prescribed at a dose of up to 100 mg per day with a single dose or 60 mg twice a day. In some patients with Zollinger-Ellison syndrome, the duration of treatment with rabeprazole was up to one year. To eradicate Helicobacter pylori, it is recommended to take 20 mg orally 2 times a day according to a specific regimen with an appropriate combination of antibiotics. The duration of treatment is 7 days.

Children: The recommended dose for children 12 years of age and older is 20 mg once daily for up to 8 weeks.